Difference between revisions of "Testingnew move2"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][unchecked revision]
Line 1: Line 1:
−
==[[Forewords and Introductions]]==
+
==Forewords and Introductions[[chapter['chapterTitle'|Overview Page Link]]==
 
     - [[General Introduction]]
 
     - [[General Introduction]]
 
     - [[ICCR datasets: Haemopoietic]]
 
     - [[ICCR datasets: Haemopoietic]]
−
==[[Myeloid proliferations and neoplasms]]==
+
==Myeloid proliferations and neoplasms[[chapter['chapterTitle'|Overview Page Link]]==
−
*[[Myeloid precursor lesions]]
+
*Myeloid precursor lesions
−
   ''italic'' [[Clonal Haematopoiesis]]
+
   ''Clonal Haematopoiesis''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Clonal haematopoiesis]]
 
     - [[Clonal haematopoiesis]]
 
     - [[Clonal cytopenias of undetermined significance]]
 
     - [[Clonal cytopenias of undetermined significance]]
−
*[[Myeloproliferative neoplasms]]
+
*Myeloproliferative neoplasms
−
   ''italic''[[Myeloproliferative neoplasms]]
+
   ''Myeloproliferative neoplasms''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Chronic myeloid leukaemia]]
 
     - [[Chronic myeloid leukaemia]]
Line 19: Line 19:
 
     - [[Juvenile myelomonocytic leukaemia]]
 
     - [[Juvenile myelomonocytic leukaemia]]
 
     - [[Myeloproliferative neoplasm, NOS]]
 
     - [[Myeloproliferative neoplasm, NOS]]
−
*[[Mastocytosis]]
+
*Mastocytosis
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Cutaneous mastocytosis]]
 
     - [[Cutaneous mastocytosis]]
 
     - [[Systemic mastocytosis]]
 
     - [[Systemic mastocytosis]]
 
     - [[Mast cell sarcoma]]
 
     - [[Mast cell sarcoma]]
−
*[[Myelodysplastic neoplasms]]
+
*Myelodysplastic neoplasms
 
     - [[Introduction]]
 
     - [[Introduction]]
−
   ''italic''[[Myelodysplastic neoplasms, with defining genetic abnormalities]]
+
   ''Myelodysplastic neoplasms, with defining genetic abnormalities''
 
     - [[Myelodysplastic neoplasm with low blasts and 5q deletion]]
 
     - [[Myelodysplastic neoplasm with low blasts and 5q deletion]]
 
     - [[Myelodysplastic neoplasm with low blasts and SF3B1 mutation]]
 
     - [[Myelodysplastic neoplasm with low blasts and SF3B1 mutation]]
 
     - [[Myelodysplastic neoplasm with biallelic TP53 inactivation]]
 
     - [[Myelodysplastic neoplasm with biallelic TP53 inactivation]]
−
   ''italic''[[Myelodysplastic neoplasms, morphologically defined]]
+
   ''Myelodysplastic neoplasms, morphologically defined''
 
     - [[Myelodysplastic neoplasm with low blasts]]
 
     - [[Myelodysplastic neoplasm with low blasts]]
 
     - [[Myelodysplastic neoplasm, hypoplastic]]
 
     - [[Myelodysplastic neoplasm, hypoplastic]]
 
     - [[Myelodysplastic neoplasm with increased blasts]]
 
     - [[Myelodysplastic neoplasm with increased blasts]]
−
   ''italic''[[Myelodysplastic neoplasms of childhood]]
+
   ''Myelodysplastic neoplasms of childhood''
 
     - [[Childhood myelodysplastic neoplasm with low blasts]]
 
     - [[Childhood myelodysplastic neoplasm with low blasts]]
 
     - [[Childhood myelodysplastic neoplasm with increased blasts]]
 
     - [[Childhood myelodysplastic neoplasm with increased blasts]]
−
*[[Myelodysplastic/myeloproliferative neoplasms]]
+
*Myelodysplastic/myeloproliferative neoplasms
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Chronic myelomonocytic leukaemia]]
 
     - [[Chronic myelomonocytic leukaemia]]
Line 43: Line 43:
 
     - [[Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]]
 
     - [[Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]]
 
     - [[Myelodysplastic/myeloproliferative neoplasm, NOS]]
 
     - [[Myelodysplastic/myeloproliferative neoplasm, NOS]]
−
*[[Acute myeloid leukaemia]]
+
*Acute myeloid leukaemia
 
     - [[Introduction]]
 
     - [[Introduction]]
−
   ''italic''[[Acute myeloid leukaemia with defining genetic abnormalities]]
+
   ''Acute myeloid leukaemia with defining genetic abnormalities''
 
     - [[Acute promyelocytic leukaemia with PML::RARA fusion]]
 
     - [[Acute promyelocytic leukaemia with PML::RARA fusion]]
 
     - [[Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion]]
 
     - [[Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion]]
Line 59: Line 59:
 
     - [[Acute myeloid leukaemia, myelodysplasia-related]]
 
     - [[Acute myeloid leukaemia, myelodysplasia-related]]
 
     - [[Acute myeloid leukaemia with other defined genetic alterations]]
 
     - [[Acute myeloid leukaemia with other defined genetic alterations]]
−
   ''italic''[[Acute myeloid leukaemia, defined by differentiation]]
+
   ''Acute myeloid leukaemia, defined by differentiation''
 
     - [[Acute myeloid leukaemia with minimal differentiation]]
 
     - [[Acute myeloid leukaemia with minimal differentiation]]
 
     - [[Acute myeloid leukaemia without maturation]]
 
     - [[Acute myeloid leukaemia without maturation]]
Line 68: Line 68:
 
     - [[Acute erythroid leukaemia]]
 
     - [[Acute erythroid leukaemia]]
 
     - [[Acute megakaryoblastic leukaemia]]
 
     - [[Acute megakaryoblastic leukaemia]]
−
   ''italic''[[Myeloid sarcoma]]
+
   ''Myeloid sarcoma''
 
     - [[Myeloid sarcoma]]
 
     - [[Myeloid sarcoma]]
−
*[[Myeloid neoplasms, secondary]]
+
*Myeloid neoplasms, secondary
−
   ''italic''[[Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions]]
+
   ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Myeloid neoplasm post cytotoxic therapy]]
 
     - [[Myeloid neoplasm post cytotoxic therapy]]
 
     - [[Myeloid neoplasms associated with germline predisposition]]
 
     - [[Myeloid neoplasms associated with germline predisposition]]
 
     - [[Myeloid proliferations associated with Down syndrome]]
 
     - [[Myeloid proliferations associated with Down syndrome]]
−
*[[Myeloid/lymphoid neoplasms]]
+
*Myeloid/lymphoid neoplasms
−
   ''italic''[[Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement]]
+
   ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Myeloid/lymphoid neoplasm with PDGFRA rearrangement]]
 
     - [[Myeloid/lymphoid neoplasm with PDGFRA rearrangement]]
Line 86: Line 86:
 
     - [[Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]]
 
     - [[Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]]
 
     - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]]
 
     - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]]
−
*[[Acute leukaemias of mixed or ambiguous lineage]]
+
*Acute leukaemias of mixed or ambiguous lineage
 
     - [[Introduction]]
 
     - [[Introduction]]
−
   ''italic''[[Acute leukaemia of ambiguous lineage with defining genetic abnormalities]]
+
   ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities''
 
     - [[Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]]
 
     - [[Mixed-phenotype acute leukaemia with BCR::ABL1 fusion]]
 
     - [[Mixed-phenotype acute leukaemia with KMT2A rearrangement]]
 
     - [[Mixed-phenotype acute leukaemia with KMT2A rearrangement]]
 
     - [[Acute leukaemia of ambiguous lineage with other defined genetic alterations ]]
 
     - [[Acute leukaemia of ambiguous lineage with other defined genetic alterations ]]
−
   ''italic''[[Acute leukaemia of ambiguous lineage, immunophenotypically defined]]
+
   ''Acute leukaemia of ambiguous lineage, immunophenotypically defined''
 
     - [[Mixed-phenotype acute leukaemia, B/myeloid]]
 
     - [[Mixed-phenotype acute leukaemia, B/myeloid]]
 
     - [[Mixed-phenotype acute leukaemia, T/myeloid]]
 
     - [[Mixed-phenotype acute leukaemia, T/myeloid]]
Line 98: Line 98:
 
     - [[Acute leukaemia of ambiguous lineage, NOS]]
 
     - [[Acute leukaemia of ambiguous lineage, NOS]]
 
     - [[Acute undifferentiated leukaemia]]
 
     - [[Acute undifferentiated leukaemia]]
−
==[[Histiocytic/Dendritic cell neoplasms]]==
+
==Histiocytic/Dendritic cell neoplasms[[chapter['chapterTitle'|Overview Page Link]]==
 
     - [[Introduction]]
 
     - [[Introduction]]
−
*[[Plasmacytoid dendritic cell neoplasms]]
+
*Plasmacytoid dendritic cell neoplasms
−
   ''italic''[[Plasmacytoid dendritic cell neoplasms]]
+
   ''Plasmacytoid dendritic cell neoplasms''
 
     - [[Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]]
 
     - [[Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]]
 
     - [[Blastic plasmacytoid dendritic cell neoplasm]]
 
     - [[Blastic plasmacytoid dendritic cell neoplasm]]
−
*[[Langerhans cell and other dendritic cell neoplasms]]
+
*Langerhans cell and other dendritic cell neoplasms
−
   ''italic''[[Langerhans cells neoplasms]]
+
   ''Langerhans cells neoplasms''
 
     - [[Langerhans cell histiocytosis]]
 
     - [[Langerhans cell histiocytosis]]
 
     - [[Langerhans cell sarcoma]]
 
     - [[Langerhans cell sarcoma]]
−
   ''italic''[[Other dendritic cell neoplasms]]
+
   ''Other dendritic cell neoplasms''
 
     - [[Indeterminate dendritic cell tumour]]
 
     - [[Indeterminate dendritic cell tumour]]
 
     - [[Interdigitating dendritic cell sarcoma]]
 
     - [[Interdigitating dendritic cell sarcoma]]
−
*[[Histiocyte/macrophage neoplasms]]
+
*Histiocyte/macrophage neoplasms
−
   ''italic''[[Histiocytic neoplasms]]
+
   ''Histiocytic neoplasms''
 
     - [[Juvenile xanthogranuloma]]
 
     - [[Juvenile xanthogranuloma]]
 
     - [[Erdheim-Chester disease]]
 
     - [[Erdheim-Chester disease]]
Line 118: Line 118:
 
     - [[ALK-positive histiocytosis]]
 
     - [[ALK-positive histiocytosis]]
 
     - [[Histiocytic sarcoma]]
 
     - [[Histiocytic sarcoma]]
−
==[[B-cell lymphoid proliferations and lymphomas]]==
+
==B-cell lymphoid proliferations and lymphomas[[chapter['chapterTitle'|Overview Page Link]]==
 
     - [[Introduction to B-cell lymphoproliferative disorders and neoplasms]]
 
     - [[Introduction to B-cell lymphoproliferative disorders and neoplasms]]
−
*[[Tumour like lesions with B-cell predominance]]
+
*Tumour like lesions with B-cell predominance
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]]
 
     - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]]
Line 127: Line 127:
 
     - [[Idiopathic multicentric Castleman disease]]
 
     - [[Idiopathic multicentric Castleman disease]]
 
     - [[KSHV/HHV8-associated multicentric Castleman disease]]
 
     - [[KSHV/HHV8-associated multicentric Castleman disease]]
−
*[[Precursor B-cell neoplasms]]
+
*Precursor B-cell neoplasms
−
   ''italic''[[B-lymphoblastic leukaemias/lymphomas]]
+
   ''B-lymphoblastic leukaemias/lymphomas''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[B-lymphoblastic leukaemia/lymphoma]]
 
     - [[B-lymphoblastic leukaemia/lymphoma]]
Line 144: Line 144:
 
     - [[B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]]
 
     - [[B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]]
 
     - [[B-lymphoblastic leukaemia/lymphoma, NOS]]
 
     - [[B-lymphoblastic leukaemia/lymphoma, NOS]]
−
*[[Mature B-cell neoplasms]]
+
*Mature B-cell neoplasms
−
   ''italic''[[Pre-neoplastic and neoplastic small lymphocytic proliferations ]]
+
   ''Pre-neoplastic and neoplastic small lymphocytic proliferations ''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Monoclonal B-cell lymphocytosis]]
 
     - [[Monoclonal B-cell lymphocytosis]]
 
     - [[Chronic lymphocytic leukaemia/small lymphocytic lymphoma]]
 
     - [[Chronic lymphocytic leukaemia/small lymphocytic lymphoma]]
−
   ''italic''[[Splenic B-cell lymphomas and leukaemias]]
+
   ''Splenic B-cell lymphomas and leukaemias''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Hairy cell leukaemia]]
 
     - [[Hairy cell leukaemia]]
Line 155: Line 155:
 
     - [[Splenic diffuse red pulp small B-cell lymphoma]]
 
     - [[Splenic diffuse red pulp small B-cell lymphoma]]
 
     - [[Splenic B-cell lymphoma/leukaemia with prominent nucleoli]]
 
     - [[Splenic B-cell lymphoma/leukaemia with prominent nucleoli]]
−
   ''italic''[[Lymphoplasmacytic lymphoma]]
+
   ''Lymphoplasmacytic lymphoma''
 
     - [[Lymphoplasmacytic lymphoma]]
 
     - [[Lymphoplasmacytic lymphoma]]
−
   ''italic''[[Marginal zone lymphoma]]
+
   ''Marginal zone lymphoma''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]]
 
     - [[Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue]]
Line 163: Line 163:
 
     - [[Nodal marginal zone lymphoma]]
 
     - [[Nodal marginal zone lymphoma]]
 
     - [[Paediatric nodal marginal zone lymphoma]]
 
     - [[Paediatric nodal marginal zone lymphoma]]
−
   ''italic''[[Follicular lymphoma]]
+
   ''Follicular lymphoma''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[In situ follicular B-cell neoplasm]]
 
     - [[In situ follicular B-cell neoplasm]]
Line 169: Line 169:
 
     - [[Paediatric-type follicular lymphoma]]
 
     - [[Paediatric-type follicular lymphoma]]
 
     - [[Duodenal-type follicular lymphoma]]
 
     - [[Duodenal-type follicular lymphoma]]
−
   ''italic''[[Cutaneous follicle centre lymphoma]]
+
   ''Cutaneous follicle centre lymphoma''
 
     - [[Primary cutaneous follicle centre lymphoma]]
 
     - [[Primary cutaneous follicle centre lymphoma]]
−
   ''italic''[[Mantle cell lymphoma]]
+
   ''Mantle cell lymphoma''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[In situ mantle cell neoplasm]]
 
     - [[In situ mantle cell neoplasm]]
 
     - [[Mantle cell lymphoma]]
 
     - [[Mantle cell lymphoma]]
 
     - [[Leukaemic non-nodal mantle cell lymphoma]]
 
     - [[Leukaemic non-nodal mantle cell lymphoma]]
−
   ''italic''[[Transformations of indolent B-cell lymphomas]]
+
   ''Transformations of indolent B-cell lymphomas''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Transformations of indolent B-cell lymphomas]]
 
     - [[Transformations of indolent B-cell lymphomas]]
−
   ''italic''[[Large B-cell lymphomas]]
+
   ''Large B-cell lymphomas''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Diffuse large B-cell lymphoma, NOS]]
 
     - [[Diffuse large B-cell lymphoma, NOS]]
Line 199: Line 199:
 
     - [[Mediastinal grey zone lymphoma]]
 
     - [[Mediastinal grey zone lymphoma]]
 
     - [[High-grade B-cell lymphoma, NOS]]
 
     - [[High-grade B-cell lymphoma, NOS]]
−
   ''italic''[[Burkitt lymphoma]]
+
   ''Burkitt lymphoma''
 
     - [[Burkitt lymphoma]]
 
     - [[Burkitt lymphoma]]
−
   ''italic''[[KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas]]
+
   ''KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Primary effusion lymphoma]]
 
     - [[Primary effusion lymphoma]]
 
     - [[KSHV/HHV8-positive diffuse large B-cell lymphoma]]
 
     - [[KSHV/HHV8-positive diffuse large B-cell lymphoma]]
 
     - [[KSHV/HHV8-positive germinotropic lymphoproliferative disorder]]
 
     - [[KSHV/HHV8-positive germinotropic lymphoproliferative disorder]]
−
   ''italic''[[Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation]]
+
   ''Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Hyperplasias arising in immune deficiency/dysregulation]]
 
     - [[Hyperplasias arising in immune deficiency/dysregulation]]
Line 213: Line 213:
 
     - [[Lymphomas arising in immune deficiency / dysregulation ]]
 
     - [[Lymphomas arising in immune deficiency / dysregulation ]]
 
     - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]]
 
     - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]]
−
*[[Hodgkin lymphoma]]
+
*Hodgkin lymphoma
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Classic Hodgkin lymphoma ]]
 
     - [[Classic Hodgkin lymphoma ]]
 
     - [[Nodular lymphocyte predominant Hodgkin lymphoma]]
 
     - [[Nodular lymphocyte predominant Hodgkin lymphoma]]
−
*[[Plasma cell neoplasms and other diseases with paraproteins]]
+
*Plasma cell neoplasms and other diseases with paraproteins
 
     - [[Introduction]]
 
     - [[Introduction]]
−
   ''italic''[[Monoclonal gammopathies]]
+
   ''Monoclonal gammopathies''
 
     - [[Cold agglutinin disease ]]
 
     - [[Cold agglutinin disease ]]
 
     - [[IgM monoclonal gammopathy of undetermined significance]]
 
     - [[IgM monoclonal gammopathy of undetermined significance]]
 
     - [[Non-IgM monoclonal gammopathy of undetermined significance]]
 
     - [[Non-IgM monoclonal gammopathy of undetermined significance]]
 
     - [[Monoclonal gammopathy of renal significance]]
 
     - [[Monoclonal gammopathy of renal significance]]
−
   ''italic''[[Diseases with monoclonal immunoglobulin deposition]]
+
   ''Diseases with monoclonal immunoglobulin deposition''
 
     - [[Immunoglobulin-related (AL) amyloidosis]]
 
     - [[Immunoglobulin-related (AL) amyloidosis]]
 
     - [[Monoclonal immunoglobulin deposition disease]]
 
     - [[Monoclonal immunoglobulin deposition disease]]
−
   ''italic''[[Heavy chain diseases]]
+
   ''Heavy chain diseases''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Mu heavy chain disease]]
 
     - [[Mu heavy chain disease]]
 
     - [[Gamma heavy chain disease]]
 
     - [[Gamma heavy chain disease]]
 
     - [[Alpha heavy chain disease]]
 
     - [[Alpha heavy chain disease]]
−
   ''italic''[[Plasma cell neoplasms]]
+
   ''Plasma cell neoplasms''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Plasmacytoma]]
 
     - [[Plasmacytoma]]
 
     - [[Plasma cell myeloma / multiple myeloma]]
 
     - [[Plasma cell myeloma / multiple myeloma]]
 
     - [[Plasma cell neoplasms with associated paraneoplastic syndrome]]
 
     - [[Plasma cell neoplasms with associated paraneoplastic syndrome]]
−
==[[T-cell and NK-cell lymphoid proliferations and lymphomas ]]==
+
==T-cell and NK-cell lymphoid proliferations and lymphomas [[chapter['chapterTitle'|Overview Page Link]]==
 
     - [[Introduction]]
 
     - [[Introduction]]
−
*[[Tumour-like lesions with T-cell predominance]]
+
*Tumour-like lesions with T-cell predominance
 
     - [[Kikuchi-Fujimoto disease]]
 
     - [[Kikuchi-Fujimoto disease]]
 
     - [[Autoimmune lymphoproliferative syndrome]]
 
     - [[Autoimmune lymphoproliferative syndrome]]
 
     - [[Indolent T-lymphoblastic proliferation]]
 
     - [[Indolent T-lymphoblastic proliferation]]
−
*[[Precursor T-cell neoplasms]]
+
*Precursor T-cell neoplasms
−
   ''italic''[[T-lymphoblastic leukaemia / lymphoma]]
+
   ''T-lymphoblastic leukaemia / lymphoma''
 
     - [[T-lymphoblastic leukaemia / lymphoma, NOS]]
 
     - [[T-lymphoblastic leukaemia / lymphoma, NOS]]
 
     - [[Early T-precursor lymphoblastic leukaemia / lymphoma ]]
 
     - [[Early T-precursor lymphoblastic leukaemia / lymphoma ]]
−
*[[Mature T-cell and NK-cell neoplasms]]
+
*Mature T-cell and NK-cell neoplasms
−
   ''italic''[[Mature T-cell and NK-cell leukaemias]]
+
   ''Mature T-cell and NK-cell leukaemias''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[T-prolymphocytic leukaemia]]
 
     - [[T-prolymphocytic leukaemia]]
Line 256: Line 256:
 
     - [[Sezary syndrome]]
 
     - [[Sezary syndrome]]
 
     - [[Aggressive NK-cell leukaemia]]
 
     - [[Aggressive NK-cell leukaemia]]
−
   ''italic''[[Primary cutaneous T-cell lymphoid proliferations and lymphomas]]
+
   ''Primary cutaneous T-cell lymphoid proliferations and lymphomas''
 
     - [[Introduction to primary cutaneous T-cell neoplasms]]
 
     - [[Introduction to primary cutaneous T-cell neoplasms]]
 
     - [[Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]]
 
     - [[Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder]]
Line 267: Line 267:
 
     - [[Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]]
 
     - [[Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma]]
 
     - [[Primary cutaneous peripheral T-cell lymphoma, NOS]]
 
     - [[Primary cutaneous peripheral T-cell lymphoma, NOS]]
−
   ''italic''[[Intestinal T-cell and NK-cell lymphoid proliferations and lymphomas]]
+
   ''Intestinal T-cell and NK-cell lymphoid proliferations and lymphomas''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Indolent T-cell lymphoma of the gastrointestinal tract]]
 
     - [[Indolent T-cell lymphoma of the gastrointestinal tract]]
Line 274: Line 274:
 
     - [[Monomorphic epitheliotropic intestinal T-cell lymphoma]]
 
     - [[Monomorphic epitheliotropic intestinal T-cell lymphoma]]
 
     - [[Intestinal T-cell lymphoma, NOS]]
 
     - [[Intestinal T-cell lymphoma, NOS]]
−
   ''italic''[[Hepatosplenic T-cell lymphoma]]
+
   ''Hepatosplenic T-cell lymphoma''
 
     - [[Hepatosplenic T-cell lymphoma]]
 
     - [[Hepatosplenic T-cell lymphoma]]
−
   ''italic''[[Anaplastic large cell lymphoma]]
+
   ''Anaplastic large cell lymphoma''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[ALK-positive anaplastic large cell lymphoma]]
 
     - [[ALK-positive anaplastic large cell lymphoma]]
 
     - [[ALK-negative anaplastic large cell lymphoma]]
 
     - [[ALK-negative anaplastic large cell lymphoma]]
 
     - [[Breast implant-associated anaplastic large cell lymphoma]]
 
     - [[Breast implant-associated anaplastic large cell lymphoma]]
−
   ''italic''[[Nodal T-follicular helper (TFH) cell lymphoma]]
+
   ''Nodal T-follicular helper (TFH) cell lymphoma''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Nodal TFH cell lymphoma, angioimmunoblastic-type]]
 
     - [[Nodal TFH cell lymphoma, angioimmunoblastic-type]]
 
     - [[Nodal TFH cell lymphoma, follicular-type]]
 
     - [[Nodal TFH cell lymphoma, follicular-type]]
 
     - [[Nodal TFH cell lymphoma, NOS]]
 
     - [[Nodal TFH cell lymphoma, NOS]]
−
   ''italic''[[Other peripheral T-cell lymphomas]]
+
   ''Other peripheral T-cell lymphomas''
 
     - [[Peripheral T-cell lymphoma, NOS]]
 
     - [[Peripheral T-cell lymphoma, NOS]]
−
   ''italic''[[EBV-positive NK-cell and T-cell lymphomas]]
+
   ''EBV-positive NK-cell and T-cell lymphomas''
 
     - [[EBV-positive nodal T- and NK-cell lymphoma]]
 
     - [[EBV-positive nodal T- and NK-cell lymphoma]]
 
     - [[Extranodal NK/T-cell lymphoma]]
 
     - [[Extranodal NK/T-cell lymphoma]]
−
   ''italic''[[EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood]]
+
   ''EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood''
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Severe mosquito bite allergy]]
 
     - [[Severe mosquito bite allergy]]
Line 297: Line 297:
 
     - [[Systemic chronic active EBV disease]]
 
     - [[Systemic chronic active EBV disease]]
 
     - [[Systemic EBV-positive T-cell lymphoma of childhood]]
 
     - [[Systemic EBV-positive T-cell lymphoma of childhood]]
−
==[[Stroma-derived neoplasms of lymphoid tissues]]==
+
==Stroma-derived neoplasms of lymphoid tissues[[chapter['chapterTitle'|Overview Page Link]]==
 
     - [[Introduction]]
 
     - [[Introduction]]
−
*[[Mesenchymal dendritic cell neoplasms]]
+
*Mesenchymal dendritic cell neoplasms
−
   ''italic''[[Follicular dendritic cell neoplasms]]
+
   ''Follicular dendritic cell neoplasms''
 
     - [[Follicular dendritic cell sarcoma]]
 
     - [[Follicular dendritic cell sarcoma]]
 
     - [[EBV-positive inflammatory follicular dendritic cell sarcoma]]
 
     - [[EBV-positive inflammatory follicular dendritic cell sarcoma]]
 
     - [[Fibroblastic reticular cell tumour]]
 
     - [[Fibroblastic reticular cell tumour]]
−
*[[Myofibroblastic tumours]]
+
*Myofibroblastic tumours
−
   ''italic''[[Myofibroblastic tumour]]
+
   ''Myofibroblastic tumour''
 
     - [[Intranodal palisaded myofibroblastoma]]
 
     - [[Intranodal palisaded myofibroblastoma]]
−
*[[Spleen-specific vascular-stromal tumours]]
+
*Spleen-specific vascular-stromal tumours
−
   ''italic''[[Splenic vascular-stromal tumours]]
+
   ''Splenic vascular-stromal tumours''
 
     - [[Littoral cell angioma]]
 
     - [[Littoral cell angioma]]
 
     - [[Splenic hamartoma]]
 
     - [[Splenic hamartoma]]
 
     - [[Sclerosing angiomatoid nodular transformation (SANT) of spleen]]
 
     - [[Sclerosing angiomatoid nodular transformation (SANT) of spleen]]
−
==[[Genetic tumour syndromes]]==
+
==Genetic tumour syndromes[[chapter['chapterTitle'|Overview Page Link]]==
 
     - [[Introduction]]
 
     - [[Introduction]]
 
     - [[Fanconi anaemia]]
 
     - [[Fanconi anaemia]]

Revision as of 11:37, 25 August 2022

Forewords and Introductions[[chapter['chapterTitle'|Overview Page Link]]

   - General Introduction
   - ICCR datasets: Haemopoietic

Myeloid proliferations and neoplasms[[chapter['chapterTitle'|Overview Page Link]]

  • Myeloid precursor lesions
 Clonal Haematopoiesis
   - Introduction
   - Clonal haematopoiesis
   - Clonal cytopenias of undetermined significance
  • Myeloproliferative neoplasms
 Myeloproliferative neoplasms
   - Introduction
   - Chronic myeloid leukaemia
   - Chronic neutrophilic leukaemia
   - Chronic eosinophilic leukaemia
   - Polycythaemia vera
   - Essential thrombocythaemia
   - Primary myelofibrosis
   - Juvenile myelomonocytic leukaemia
   - Myeloproliferative neoplasm, NOS
  • Mastocytosis
   - Introduction
   - Cutaneous mastocytosis
   - Systemic mastocytosis
   - Mast cell sarcoma
  • Myelodysplastic neoplasms
   - Introduction
 Myelodysplastic neoplasms, with defining genetic abnormalities
   - Myelodysplastic neoplasm with low blasts and 5q deletion
   - Myelodysplastic neoplasm with low blasts and SF3B1 mutation
   - Myelodysplastic neoplasm with biallelic TP53 inactivation
 Myelodysplastic neoplasms, morphologically defined
   - Myelodysplastic neoplasm with low blasts
   - Myelodysplastic neoplasm, hypoplastic
   - Myelodysplastic neoplasm with increased blasts
 Myelodysplastic neoplasms of childhood
   - Childhood myelodysplastic neoplasm with low blasts
   - Childhood myelodysplastic neoplasm with increased blasts
  • Myelodysplastic/myeloproliferative neoplasms
   - Introduction
   - Chronic myelomonocytic leukaemia
   - Myelodysplastic/myeloproliferative neoplasm with neutrophilia
   - Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis
   - Myelodysplastic/myeloproliferative neoplasm, NOS
  • Acute myeloid leukaemia
   - Introduction
 Acute myeloid leukaemia with defining genetic abnormalities
   - Acute promyelocytic leukaemia with PML::RARA fusion
   - Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion
   - Acute myeloid leukaemia with CBFB::MYH11 fusion
   - Acute myeloid leukaemia with DEK::NUP214 fusion
   - Acute myeloid leukaemia with RBM15::MRTFA fusion
   - Acute myeloid leukaemia with BCR::ABL1 fusion
   - Acute myeloid leukaemia with KMT2A rearrangement
   - Acute myeloid leukaemia with MECOM rearrangement
   - Acute myeloid leukaemia with NUP98 rearrangement
   - Acute myeloid leukaemia with NPM1 mutation
   - Acute myeloid leukaemia with CEBPA mutation
   - Acute myeloid leukaemia, myelodysplasia-related
   - Acute myeloid leukaemia with other defined genetic alterations
 Acute myeloid leukaemia, defined by differentiation
   - Acute myeloid leukaemia with minimal differentiation
   - Acute myeloid leukaemia without maturation
   - Acute myeloid leukaemia with maturation
   - Acute basophilic leukaemia
   - Acute myelomonocytic leukaemia
   - Acute monocytic leukaemia
   - Acute erythroid leukaemia
   - Acute megakaryoblastic leukaemia
 Myeloid sarcoma
   - Myeloid sarcoma
  • Myeloid neoplasms, secondary
 Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions
   - Introduction
   - Myeloid neoplasm post cytotoxic therapy
   - Myeloid neoplasms associated with germline predisposition
   - Myeloid proliferations associated with Down syndrome
  • Myeloid/lymphoid neoplasms
 Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement
   - Introduction
   - Myeloid/lymphoid neoplasm with PDGFRA rearrangement
   - Myeloid/lymphoid neoplasm with PDGFRB rearrangement
   - Myeloid/lymphoid neoplasm with FGFR1 rearrangement
   - Myeloid/lymphoid neoplasm with JAK2 rearrangement
   - Myeloid/lymphoid neoplasm with FLT3 rearrangement
   - Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion
   - Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes
  • Acute leukaemias of mixed or ambiguous lineage
   - Introduction
 Acute leukaemia of ambiguous lineage with defining genetic abnormalities
   - Mixed-phenotype acute leukaemia with BCR::ABL1 fusion
   - Mixed-phenotype acute leukaemia with KMT2A rearrangement
   - Acute leukaemia of ambiguous lineage with other defined genetic alterations 
 Acute leukaemia of ambiguous lineage, immunophenotypically defined
   - Mixed-phenotype acute leukaemia, B/myeloid
   - Mixed-phenotype acute leukaemia, T/myeloid
   - Mixed-phenotype acute leukaemia, rare types
   - Acute leukaemia of ambiguous lineage, NOS
   - Acute undifferentiated leukaemia

Histiocytic/Dendritic cell neoplasms[[chapter['chapterTitle'|Overview Page Link]]

   - Introduction
  • Plasmacytoid dendritic cell neoplasms
 Plasmacytoid dendritic cell neoplasms
   - Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm
   - Blastic plasmacytoid dendritic cell neoplasm
  • Langerhans cell and other dendritic cell neoplasms
 Langerhans cells neoplasms
   - Langerhans cell histiocytosis
   - Langerhans cell sarcoma
 Other dendritic cell neoplasms
   - Indeterminate dendritic cell tumour
   - Interdigitating dendritic cell sarcoma
  • Histiocyte/macrophage neoplasms
 Histiocytic neoplasms
   - Juvenile xanthogranuloma
   - Erdheim-Chester disease
   - Rosai-Dorfman Disease
   - ALK-positive histiocytosis
   - Histiocytic sarcoma

B-cell lymphoid proliferations and lymphomas[[chapter['chapterTitle'|Overview Page Link]]

   - Introduction to B-cell lymphoproliferative disorders and neoplasms
  • Tumour like lesions with B-cell predominance
   - Introduction
   - Reactive B-cell rich lymphoid proliferations that can mimic lymphoma
   - IgG4-related disease
   - Unicentric Castleman disease
   - Idiopathic multicentric Castleman disease
   - KSHV/HHV8-associated multicentric Castleman disease
  • Precursor B-cell neoplasms
 B-lymphoblastic leukaemias/lymphomas
   - Introduction
   - B-lymphoblastic leukaemia/lymphoma
   - B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy
   - B-lymphoblastic leukaemia/lymphoma with hypodiploidy
   - B-lymphoblastic leukaemia/lymphoma with iAMP21
   - B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion
   - B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features
   - B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement
   - B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion
   - B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features
   - B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion
   - B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion 
   - B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion
   - B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations
   - B-lymphoblastic leukaemia/lymphoma, NOS
  • Mature B-cell neoplasms
 Pre-neoplastic and neoplastic small lymphocytic proliferations 
   - Introduction
   - Monoclonal B-cell lymphocytosis
   - Chronic lymphocytic leukaemia/small lymphocytic lymphoma
 Splenic B-cell lymphomas and leukaemias
   - Introduction
   - Hairy cell leukaemia
   - Splenic marginal zone lymphoma
   - Splenic diffuse red pulp small B-cell lymphoma
   - Splenic B-cell lymphoma/leukaemia with prominent nucleoli
 Lymphoplasmacytic lymphoma
   - Lymphoplasmacytic lymphoma
 Marginal zone lymphoma
   - Introduction
   - Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
   - Primary cutaneous marginal zone lymphoma 
   - Nodal marginal zone lymphoma
   - Paediatric nodal marginal zone lymphoma
 Follicular lymphoma
   - Introduction
   - In situ follicular B-cell neoplasm
   - Follicular lymphoma
   - Paediatric-type follicular lymphoma
   - Duodenal-type follicular lymphoma
 Cutaneous follicle centre lymphoma
   - Primary cutaneous follicle centre lymphoma
 Mantle cell lymphoma
   - Introduction
   - In situ mantle cell neoplasm
   - Mantle cell lymphoma
   - Leukaemic non-nodal mantle cell lymphoma
 Transformations of indolent B-cell lymphomas
   - Introduction
   - Transformations of indolent B-cell lymphomas
 Large B-cell lymphomas
   - Introduction
   - Diffuse large B-cell lymphoma, NOS
   - T-cell/histiocyte-rich large B-cell lymphoma
   - Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements
   - ALK-positive large B-cell lymphoma
   - Large B-cell lymphoma with IRF4 rearrangement
   - High grade B-cell lymphoma with 11q aberrations
   - Lymphomatoid granulomatosis
   - EBV-positive diffuse large B-cell lymphoma
   - Diffuse large B-cell lymphoma associated with chronic inflammation
   - Fibrin-associated large B-cell lymphoma
   - Fluid overload-associated large B-cell lymphoma
   - Plasmablastic lymphoma
   - Primary large B-cell lymphoma of immune-privileged sites
   - Primary cutaneous diffuse large B-cell lymphoma, leg type
   - Intravascular large B-cell lymphoma
   - Primary mediastinal large B-cell lymphoma
   - Mediastinal grey zone lymphoma
   - High-grade B-cell lymphoma, NOS
 Burkitt lymphoma
   - Burkitt lymphoma
 KSHV/HHV8-associated B-cell lymphoid proliferations and lymphomas
   - Introduction
   - Primary effusion lymphoma
   - KSHV/HHV8-positive diffuse large B-cell lymphoma
   - KSHV/HHV8-positive germinotropic lymphoproliferative disorder
 Lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation
   - Introduction
   - Hyperplasias arising in immune deficiency/dysregulation
   - Polymorphic lymphoproliferative disorders arising in immune deficiency / dysregulation 
   - EBV-positive mucocutaneous ulcer
   - Lymphomas arising in immune deficiency / dysregulation 
   - Inborn error of immunity-associated lymphoid proliferations and lymphomas
  • Hodgkin lymphoma
   - Introduction
   - Classic Hodgkin lymphoma 
   - Nodular lymphocyte predominant Hodgkin lymphoma
  • Plasma cell neoplasms and other diseases with paraproteins
   - Introduction
 Monoclonal gammopathies
   - Cold agglutinin disease 
   - IgM monoclonal gammopathy of undetermined significance
   - Non-IgM monoclonal gammopathy of undetermined significance
   - Monoclonal gammopathy of renal significance
 Diseases with monoclonal immunoglobulin deposition
   - Immunoglobulin-related (AL) amyloidosis
   - Monoclonal immunoglobulin deposition disease
 Heavy chain diseases
   - Introduction
   - Mu heavy chain disease
   - Gamma heavy chain disease
   - Alpha heavy chain disease
 Plasma cell neoplasms
   - Introduction
   - Plasmacytoma
   - Plasma cell myeloma / multiple myeloma
   - Plasma cell neoplasms with associated paraneoplastic syndrome

T-cell and NK-cell lymphoid proliferations and lymphomas [[chapter['chapterTitle'|Overview Page Link]]

   - Introduction
  • Tumour-like lesions with T-cell predominance
   - Kikuchi-Fujimoto disease
   - Autoimmune lymphoproliferative syndrome
   - Indolent T-lymphoblastic proliferation
  • Precursor T-cell neoplasms
 T-lymphoblastic leukaemia / lymphoma
   - T-lymphoblastic leukaemia / lymphoma, NOS
   - Early T-precursor lymphoblastic leukaemia / lymphoma
  • Mature T-cell and NK-cell neoplasms
 Mature T-cell and NK-cell leukaemias
   - Introduction
   - T-prolymphocytic leukaemia
   - T-large granular lymphocytic leukaemia
   - NK-large granular lymphocytic leukaemia
   - Adult T-cell leukaemia/lymphoma
   - Sezary syndrome
   - Aggressive NK-cell leukaemia
 Primary cutaneous T-cell lymphoid proliferations and lymphomas
   - Introduction to primary cutaneous T-cell neoplasms
   - Primary cutaneous CD4-positive small or medium T-cell lymphoproliferative disorder
   - Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder
   - Mycosis fungoides
   - Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Lymphomatoid papulosis
   - Primary cutaneous CD30-positive T-cell lymphoproliferative disorder: Primary cutaneous anaplastic large cell lymphoma
   - Subcutaneous panniculitis-like T-cell lymphoma
   - Primary cutaneous gamma/delta T-cell lymphoma
   - Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma
   - Primary cutaneous peripheral T-cell lymphoma, NOS
 Intestinal T-cell and NK-cell lymphoid proliferations and lymphomas
   - Introduction
   - Indolent T-cell lymphoma of the gastrointestinal tract
   - Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract
   - Enteropathy-associated T-cell lymphoma
   - Monomorphic epitheliotropic intestinal T-cell lymphoma
   - Intestinal T-cell lymphoma, NOS
 Hepatosplenic T-cell lymphoma
   - Hepatosplenic T-cell lymphoma
 Anaplastic large cell lymphoma
   - Introduction
   - ALK-positive anaplastic large cell lymphoma
   - ALK-negative anaplastic large cell lymphoma
   - Breast implant-associated anaplastic large cell lymphoma
 Nodal T-follicular helper (TFH) cell lymphoma
   - Introduction
   - Nodal TFH cell lymphoma, angioimmunoblastic-type
   - Nodal TFH cell lymphoma, follicular-type
   - Nodal TFH cell lymphoma, NOS
 Other peripheral T-cell lymphomas
   - Peripheral T-cell lymphoma, NOS
 EBV-positive NK-cell and T-cell lymphomas
   - EBV-positive nodal T- and NK-cell lymphoma
   - Extranodal NK/T-cell lymphoma
 EBV-positive T-cell and NK-cell lymphoid proliferations and lymphomas of childhood
   - Introduction
   - Severe mosquito bite allergy
   - Hydroa vacciniforme lymphoproliferative disorder
   - Systemic chronic active EBV disease
   - Systemic EBV-positive T-cell lymphoma of childhood

Stroma-derived neoplasms of lymphoid tissues[[chapter['chapterTitle'|Overview Page Link]]

   - Introduction
  • Mesenchymal dendritic cell neoplasms
 Follicular dendritic cell neoplasms
   - Follicular dendritic cell sarcoma
   - EBV-positive inflammatory follicular dendritic cell sarcoma
   - Fibroblastic reticular cell tumour
  • Myofibroblastic tumours
 Myofibroblastic tumour
   - Intranodal palisaded myofibroblastoma
  • Spleen-specific vascular-stromal tumours
 Splenic vascular-stromal tumours
   - Littoral cell angioma
   - Splenic hamartoma
   - Sclerosing angiomatoid nodular transformation (SANT) of spleen

Genetic tumour syndromes[[chapter['chapterTitle'|Overview Page Link]]

   - Introduction
   - Fanconi anaemia
   - Bloom syndrome
   - Ataxia-telangiectasia syndrome
   - RASopathies
Retrieved from "https://ccga.io/index.php?title=Testingnew_move2&oldid=11547"